Centre Hospitalier Universitaire Sainte-Justine
Showing 1 - 25 of >10,000
Post-Extubation Assessment of Clinical Stability in ELBW Infants
Not yet recruiting
- Extremely Low Birth Weight Infants
- Oxygen saturation probe
- +2 more
-
Montreal, Quebec, Canada
- +1 more
Sep 7, 2023
Congenital Heart Disease, Child Development, Neurodevelopmental Disorders Trial in Montréal (Parent-child yoga)
Recruiting
- Congenital Heart Disease
- +3 more
- Parent-child yoga
-
Montréal, Quebec, Canada
- +1 more
Aug 11, 2023
Heart Failure Trial in Toronto (iPeer2Peer Program)
Not yet recruiting
- Heart Failure
- iPeer2Peer Program
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Jan 24, 2023
Recurrence After Emergency Presentation for Allergic REaction
Recruiting
- Anaphylaxis
- Observational
-
Calgary, Alberta, Canada
- +6 more
Nov 1, 2022
Food IgE-mediated Allergy, Immunotherapy, Omalizumab Trial in Toronto, Montréal, Sherbrooke (Omalizumab 16mg/kg, Omalizumab
Recruiting
- Food IgE-mediated Allergy
- +3 more
- Omalizumab 16mg/kg
- +3 more
-
Toronto, Ontario, Canada
- +2 more
Jan 31, 2022
Cystic Fibrosis Pulmonary Exacerbation Trial in Canada (Prednisone, Placebos)
Recruiting
- Cystic Fibrosis Pulmonary Exacerbation
- Prednisone
- Placebos
-
Calgary, Alberta, Canada
- +11 more
Nov 23, 2022
Diabetes, Type 1, Type1diabetes, Insulin Dependent Diabetes Trial in Montreal (Active arm, Control arm)
Active, not recruiting
- Diabetes Mellitus, Type 1
- +2 more
- Active arm
- Control arm
-
Montreal, Quebec, Canada
- +1 more
Nov 25, 2021
Urinary Tract Infections Trial in Montréal, Antibes, Nice (bladder stimulation, Quick wee)
Active, not recruiting
- Urinary Tract Infections
- bladder stimulation
- Quick wee
-
Montréal, Canada
- +2 more
Jul 26, 2022
Outcome of Children Post Mechanical Ventilation
Not yet recruiting
- Post Intensive Care Syndrome
-
Montreal, Quebec, Canada
- +3 more
Feb 5, 2022
Rare Histiocytic Disorders (RHDs), Juvenile Xanthogranuloma (JXG), Reticulohistiocytoma (Epithelioid Histiocytoma) Trial in
Active, not recruiting
- Rare Histiocytic Disorders (RHDs)
- +7 more
- Registry study
-
Los Angeles, California
- +13 more
Dec 13, 2022
Advanced Non CNS Tumors Trial in Worldwide (Talimogene Laherparepvec)
Completed
- Advanced Non CNS Tumors
- Talimogene Laherparepvec
-
Wilmington, Delaware
- +21 more
Dec 21, 2022
Scoliosis, Adolescent Idiopathic Scoliosis Trial in Canada, United States (Maximum Number of Screws, Minimum Number of Screws)
Completed
- Scoliosis
- Adolescent Idiopathic Scoliosis
- Maximum Number of Screws
- Minimum Number of Screws
-
Aurora, Colorado
- +13 more
Aug 2, 2022
Children After Hospitalization in Intensive Care Unit
Not yet recruiting
- Renal Disease
- +7 more
- neurocognitive tests
-
Calgary, Alberta, Canada
- +7 more
Nov 3, 2023
Sickle Cell Disease, Hemoglobinopathies Trial in Canada, United States (EDIT-301)
Recruiting
- Sickle Cell Disease
- Hemoglobinopathies
- EDIT-301
-
Oakland, California
- +18 more
Jan 10, 2023
Recurrent or Progressive Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, New Zealand (re-irradiation)
Recruiting
- Recurrent or Progressive Diffuse Intrinsic Pontine Glioma
- re-irradiation
-
Westmead, New South Wales, Australia
- +17 more
Dec 14, 2021
CVD Risk Profile in Children With HCM
Recruiting
- Hypertrophic Cardiomyopathy
-
Edmonton, Alberta, Canada
- +9 more
Aug 18, 2022
Acute Gastroenteritis, Viral Illness, Vomiting Trial in Canada (Ondansetron Oral Solution, Oral Placebo)
Recruiting
- Acute Gastroenteritis
- +3 more
- Ondansetron Oral Solution
- Oral Placebo
-
Calgary, Alberta, Canada
- +5 more
Sep 28, 2021
Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- ITMHA
- +13 more
-
Los Angeles, California
- +17 more
Jun 6, 2022
Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)
Recruiting
- Macrophage Activation Syndrome
- +6 more
-
Birmingham, Alabama
- +41 more
Jan 3, 2023
Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma Trial in United States (Elimusertib)
Recruiting
- Recurrent Alveolar Rhabdomyosarcoma
- +7 more
-
Birmingham, Alabama
- +28 more
Jan 26, 2023
Shock, Septic Trial in Philadelphia (Lactated Ringer, Normal Saline, Plasma-lyte)
Recruiting
- Shock
- Septic
- Lactated Ringer
- +2 more
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 18, 2022
Preterm Birth, Premature Birth, Complication of Prematurity Trial in Australia, Canada (Celestone + , Celestone + Celestone)
Not yet recruiting
- Preterm Birth
- +4 more
- Celestone + placebo
- Celestone + Celestone
-
Newcastle, New South Wales, Australia
- +40 more
Sep 14, 2022
Motivational Interviewing Trial in Montréal, Québec, Sherbrooke (Motivational interviewing)
Completed
- Motivational Interviewing
- Motivational interviewing
-
Montréal, Quebec, Canada
- +3 more
Apr 26, 2021
Clinical & Anthropometric Characteristics of Achondroplasia.
Active, not recruiting
- Achondroplasia
-
Torrance, California
- +32 more
Nov 16, 2022
